JPM26: Solid Biosciences banks on its AAV capsid to catalyse gene therapy success
Solid Biosciences is positioning itself for a potentially “transformative” year as it builds on its 2025 success and centres its…
Industry
-
-
Big pharma and investors re-engage in CGTs and race to scale
Panels at the Alliance for Regenerative Medicine’s Industry Briefing highlighted how CGTs are expanding beyond rare disease into broader indications,…
-
Investors bet on newer technology and indications for CGTs
As confidence grows for innovative in vivo strategies, some investors are saying they could be the future of the cell…
-
Redefining clinical trials in oncology and rare diseases across the Europe
Later this month, experts from the pharmaceutical and biotechnology industry and patient advocacy space will gather in Munich, Germany, to…
-
Metagenomi culls 25% of its workforce and replaces CEO in reshuffle
Metagenomi will slash a quarter of its workforce and switch up its CEO as part of efforts to extend its…
-
FDA halts uniQure’s plans for Huntington’s disease gene therapy
The path to approval for uniQure’s gene therapy candidate for Huntington’s disease is in doubt as the US Food and…
-
Sensei to ditch its lead candidate and cut workforce amidst strategic review
Sensei Biotherapeutics is set to abandon its sole clinical-stage asset solnerstotug as it prepares to cut its workforce and consider…
-
FDA gives first approval for recurrent respiratory papillomatosis therapy
On 14 August 2025, the US Food and Drugs Administration (FDA) approved Precigen’s Papzimeos (zopapogene imadenovec) for recurrent respiratory papillomatosis…
-
Sartorius to invest $3m for minority share in biotech start-up Nanotein
Sartorius Stedim Biotech has agreed to invest $3m in Nanotein Technologies, a US-based company engaged in the development of advanced…
-
African countries plan shift to healthcare funding autonomy amid aid cuts
African nations are preparing to transition towards greater financial independence in developing healthcare infrastructure, as international aid declines, according to…
